RGC Regencell Bioscience Holdings Limited Quarterly EPS earnings growth
How can the delivery of fragile neuropreparations be ensured amidst high thermoregulation costs? The quarterly earnings per share growth rate demonstrates volatility, where the -269.00 level reflects the current value of the metric. The solution lies in the virtualization of assets through external contractors (CRO/CMO) and the pursuit of new capital, as the experimental stage precludes the existence of stable revenue streams for Regencell Bioscience (RGC).
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_RGC_-_Regencell-Bioscience_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "regencellbioscience.com (RGC): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/10/2026 | 👁️GURU.Markets👁️")
Regencell Corp (RGC) - metric breakdowns and financial figures
- share price and expert price forecast:
- market capitalization data:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Total Debt to Equity Ratio Regencell Bioscience|RGC - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Regencell Bioscience|RGC - Company Debts|Debts to Book Capitalization Regencell|RGC - Long-Term Debt Volume|Company Short-Term Debt Regencell Bioscience|Quick Liquidity regencellbioscience.com
- earnings and market multiples details:
RGC - Net Financial Result|Projected Future Earnings Regencell Bioscience|RGC - Price to Earnings Ratio|Forward P/E Multiple Regencell|RGC - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Regencell|RGC - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Regencell Bioscience|RGC - Earnings per share for the last 12 months|Quarterly EPS earnings growth regencellbioscience.com|RGC - Net earnings per share growth this year|Earnings growth forecast for next year Regencell Bioscience
Fundamental valuation:Regencell Bioscience Holdings Limited - RGC
The analyst assesses the issuer's creditworthiness through the dynamics of net income per share. For Regencell Bioscience (RGC), this parameter is critical due to volatile cash flows and clinical trial risks. The magnitude of quarterly EPS growth measures the business's real yield, excluding market interpretation distortions. This indicator demonstrates the efficiency of capitalizing innovations under stringent FDA requirements. Any deviation on the chart requires a risk assessment of a deep drawdown.
Competitors of Regencell Bioscience (RGC)
BIIB: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Neurocrine|AXSM (Axsome Therapeutics Inc) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months ACADIA Corp ACAD|Year-over-year earnings per share growth for the last twelve months Xenon Pharmaceuticals (XENE)|Year-over-year earnings per share growth for the last twelve months VKTX (vikingtherapeutics.com)|Year-over-year earnings per share growth for the last twelve months Supernus SUPN|Catalyst Pharma - Year-over-year earnings per share growth for the last twelve months|DNLI: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months HRMY (Harmony Corp)|BHVN: Quarterly EPS earnings growth|AMLX (amylyx.com) - Year-over-year earnings per share growth for the last twelve months|TRVI (Trevi Therapeutics, Inc.) - Quarterly EPS earnings growth|Praxis Precision Medicines Inc (PRAX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Anavex Corp (AVXL)|CBLL - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Prothena Corporation PRTA|Year-over-year net earnings per share change for the last twelve months Alector Inc. (ALEC)|Annexon - Quarterly EPS earnings growth|Omeros Corporation (OMER) - Year-over-year net earnings per share growth for the last 12 months|NGNE: Quarterly EPS earnings growth|ACIU - Year-over-year net earnings per share change for the last twelve months|VYGR (Voyager Therapeutics) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months neumoratx.com NMRA|Year-over-year earnings per share growth for the last twelve months Scilex (SCLX)|Tevogen Bio Holdings Inc. - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth ACOG (Alpha Cognition Inc.)|CGTX - Year-over-year net earnings per share growth for the last 12 months|Inhibikase Therapeutics - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months cassavasciences.com|assertiotx.com (ASRT) - Year-over-year earnings per share growth for the last twelve months|Coya Therapeutics - Year-over-year earnings per one share growth for the last 12 months|VTGN (VistaGen Therapeutics, Inc.) - Quarterly EPS earnings growth|OVID - Net earnings per share growth for the trailing year|Quarterly EPS earnings growth ABOS|Year-over-year net earnings per share growth for the last 12 months cervomed.com CRVO|Year-over-year earnings per share growth for the last twelve months Alterity Therapeutics Limited ATHE|CLNN: Year-over-year earnings per share growth for the last 12 months|PepGen Corp - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months jupiterneurosciences.com|RLMD (Relmada Therapeutics) - Year-over-year net earnings per share growth for the last 12 months|annovisbio.com (ANVS) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Grace Therapeutics Inc|AIFF: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Klotho Neurosciences Inc (KLTO)|NRSN - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Reviva Pharmaceuticals RVPH|Year-over-year earnings per one share growth for the last 12 months MTVA|NeurAxis - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Helius Medical|PASG: Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Neuphoria Therapeutics NEUP|NERV (Minerva Neurosciences) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months athira.com ATHA|Year-over-year earnings per share growth for the last twelve months Addex Therapeutics Ltd (ADXN)|alzamend.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth CYCN (Cyclerion Therapeutics, Inc.)|PTIX - Year-over-year net earnings per share growth for the last 12 months|Pasithea - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Cortigent, Inc.|Avenue Therapeutics, Inc. (ATXI) - Year-over-year earnings per share growth for the last twelve months|BCLI (Brainstorm Cell Therapeutics Inc.) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months Cara Therapeutics, Inc|Year-over-year earnings per share growth for the last twelve months CHRO|Year-over-year net earnings per share growth for the last 12 months ELYM (Eliem Therapeutics)|ITCI (intracellulartherapies.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth LBPH (Longboard Pharmaceuticals, Inc.)|Marinus Pharmaceuticals Inc - Year-over-year earnings per share growth for the last twelve months|NKGen - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months NeuroBo Pharma NRBO|Sage Therapeutics, Inc. (SAGE) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months synaptogen.com (SNPX)|Year-over-year earnings per share growth for the last twelve months Trevena|Vigil Neuro (VIGL) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth WENA|Year-over-year net earnings per share growth for the last 12 months Cerevel Corp CERE
